Medical Condition News

RSS

Antidepressant use may increase risk of strokes caused by bleeding in the brain

Research shows that use of popular antidepressants is linked to an increased risk of some strokes caused by bleeding in the brain, but that the risk is low, according to a multi-study analysis published in the October 17, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Oct 2012

New way to image how brain cells coordinate with each other to control specific behaviors

A team led by MIT neuroscientists has developed a way to monitor how brain cells coordinate with each other to control specific behaviors, such as initiating movement or detecting an odor.

19 Oct 2012

Two opposing mechanisms support voluntary forgetting of unwanted memories

If only there were a way to forget that humiliating faux pas at last night's dinner party. It turns out there's not one, but two opposite ways in which the brain allows us to voluntarily forget unwanted memories, according to a study published by Cell Press October 17 in the journal Neuron.

19 Oct 2012

Study demonstrates cancer control essential for development progress, researcher says

Using data from cancer registries worldwide, researchers from the International Agency for Cancer Research (IACR) found that 169.3 million years of healthy life were lost to cancer in 2008, according to a study published on Tuesday in the Lancet, HealthDay News reports.

19 Oct 2012

New insights into wiring and firing of the social brain

New insights into the wiring and firing of the "social brain" in humans and primates reveals the brain areas important in altruistic motives and behavior, and the brain regions that respond to the pain of discrimination.

19 Oct 2012

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI.

19 Oct 2012

Islamic Azad University develops new medicated gum for motion sickness

A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild circumstances and 66 percent are affected in more severe conditions.

19 Oct 2012

Study addresses potential benefits of treating anxiety in coronary artery disease

A study published in the current issue of Psychotherapy and Psychosomatics addresses the potential benefits of treating anxiety in coronary artery disease.

19 Oct 2012

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Neuralstem, Inc. announced that it has begun dosing the second cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).

19 Oct 2012

Researchers identify brain mechanisms that regulate cocaine-seeking behavior

Researchers from the University of Wisconsin-Milwaukee (UWM) have identified mechanisms in the brain responsible for regulating cocaine-seeking behavior, providing an avenue for drug development that could greatly reduce the high relapse rate in cocaine addiction.

19 Oct 2012

Kaiser Permanente creates new electronic Exercise Vital Sign initiative

Kaiser Permanente has created a new electronic Exercise Vital Sign initiative to systematically record patients' physical activity in their electronic health records.

19 Oct 2012

Adding increased glucose monitoring can optimize perioperative care of diabetic patients

A study presented at the ANESTHESIOLOGY 2012 annual meeting revealed that adding increased glucose monitoring throughout surgical procedures will allow anesthesiologists to optimize the perioperative and surgical care of millions of diabetic patients throughout the world.

19 Oct 2012

Quick, cheap eye scan can predict brain damage in people with multiple sclerosis

An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, according to results of two Johns Hopkins studies.

19 Oct 2012

Better physical fitness linked to lower levels of insulin among teenagers

Researchers at the UPM are collaborating on new studies regarding workouts and healthy eating habits with controlled levels of insulin and leptin what can prevent from obesity and diabetes.

19 Oct 2012

Research to determine how genes contribute to Type 1 diabetes

Diabetes is a chronic, debilitating disease which affects nearly 26 million Americans. As many as three million people have Type 1 diabetes or juvenile diabetes that usually occurs in children or young adults.

19 Oct 2012

Ustekinumab shows positive results in decreasing debilitating effects of Crohn's Disease

Ustekinumab, an antibody proven to treat the skin condition psoriasis, has now shown positive results in decreasing the debilitating effects of Crohn's Disease, according to researchers at the University of California San Diego, School of Medicine.

18 Oct 2012

New research sheds light on consequence of overeating

New research from Mount Sinai School of Medicine sheds light on how overeating can cause a malfunction in brain insulin signaling, and lead to obesity and diabetes.

18 Oct 2012

Personalized medicine research strikes early for heart genes

A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida.

18 Oct 2012

Researchers identify painful symptoms of sickle cell disease

Researchers at Drexel University have identified the physical forces in red blood cells and blood vessels underlying the painful symptoms of sickle cell disease.

18 Oct 2012

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Pfizer Inc. announced today that a Phase 3 study of INLYTA (axitinib) did not meet its primary endpoint of demonstrating statistically significantly longer progression-free survival, versus sorafenib, in treatment-naïve patients with advanced renal cell carcinoma.

18 Oct 2012

Medical Condition News

Antidepressant use may increase risk of strokes caused by bleeding in the brain

New way to image how brain cells coordinate with each other to control specific behaviors

Two opposing mechanisms support voluntary forgetting of unwanted memories

Study demonstrates cancer control essential for development progress, researcher says

New insights into wiring and firing of the social brain

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Islamic Azad University develops new medicated gum for motion sickness

Study addresses potential benefits of treating anxiety in coronary artery disease

Neuralstem initiates second cohort NSI-189 Phase Ib trial in major depressive disorder

Researchers identify brain mechanisms that regulate cocaine-seeking behavior

Kaiser Permanente creates new electronic Exercise Vital Sign initiative

Adding increased glucose monitoring can optimize perioperative care of diabetic patients

Quick, cheap eye scan can predict brain damage in people with multiple sclerosis

Better physical fitness linked to lower levels of insulin among teenagers

Research to determine how genes contribute to Type 1 diabetes

Ustekinumab shows positive results in decreasing debilitating effects of Crohn's Disease

New research sheds light on consequence of overeating

Personalized medicine research strikes early for heart genes

Researchers identify painful symptoms of sickle cell disease

Phase 3 study of INLYTA fails to meet primary endpoint in treatment-naïve patients with RCC

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News